Clinical trial
Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics (PROSPECT): a National, Multicenter, Retrospective-prospective, Cohort Study
NCT06001073 is registered in ClinicalTrials.gov with First Affiliated Hospital Xi'an Jiaotong University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prognosis Prediction System of Patients With Cardiovascular and Cerebrovascular Diseases Based on Multi-omics (PROSPECT): a National, Multicenter, Retrospective-prospective, Cohort Study
- Lead sponsor
- First Affiliated Hospital Xi'an Jiaotong University
- Phase
- Observational
- Overall status
- Recruiting
- Start date
- December 5, 2022
- Completion date
- December 31, 2028
- Enrollment
- 25,000 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
aortic dissection, arrhythmias, cardiac, brain neoplasms, cardiomyopathies, coronary artery disease, heart neoplasms, heart valve diseases, hemorrhagic cerebrovascular disease, hypertension, ischemic cerebrovascular disease, myocarditis, structural heart disease